FGEN Fibrogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FGEN

Price (delayed)

$1.27

Market cap

$125.44M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.92

Enterprise value

$215.71M

FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue ...

Highlights
The company's EPS rose by 7% YoY and by 4.9% QoQ
The net income is up by 3.4% since the previous quarter and by 3.2% year-on-year
FGEN's gross profit is up by 7% year-on-year but it is down by 6% since the previous quarter
The company's revenue rose by 5% YoY but it fell by 4.7% QoQ
The company's debt rose by 47% YoY
FGEN's equity is down by 30% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.fibrogen.com
Peers: ILMN A HBIO PACB

Key stats

What are the main financial stats of FGEN
Market
Shares outstanding
98.77M
Market cap
$125.44M
Enterprise value
$215.71M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.46
Earnings
Revenue
$147.75M
EBIT
-$268.7M
EBITDA
-$258.77M
Free cash flow
-$317.54M
Per share
EPS
-$2.92
Free cash flow per share
-$3.26
Book value per share
-$2.08
Revenue per share
$1.52
TBVPS
$4.35
Balance sheet
Total assets
$423.53M
Total liabilities
$585.73M
Debt
$203.96M
Equity
-$204.17M
Working capital
$113.89M
Liquidity
Debt to equity
-1
Current ratio
1.52
Quick ratio
1.14
Net debt/EBITDA
-0.35
Margins
EBITDA margin
-175.1%
Gross margin
87.2%
Net margin
-192.4%
Operating margin
-190.7%
Efficiency
Return on assets
-58.7%
Return on equity
N/A
Return on invested capital
-87.2%
Return on capital employed
-130.5%
Return on sales
-181.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FGEN stock price

How has the Fibrogen stock price performed over time
Intraday
-2.31%
1 week
-11.19%
1 month
-39.23%
1 year
-93.83%
YTD
43.29%
QTD
-45.96%

Financial performance

How have Fibrogen's revenue and profit performed over time
Revenue
$147.75M
Gross profit
$128.9M
Operating income
-$281.82M
Net income
-$284.23M
Gross margin
87.2%
Net margin
-192.4%
Fibrogen's operating margin has increased by 11% YoY
The company's net margin rose by 8% YoY
FGEN's gross profit is up by 7% year-on-year but it is down by 6% since the previous quarter
FGEN's operating income is up by 6% year-on-year and by 4.1% since the previous quarter

Growth

What is Fibrogen's growth rate over time

Valuation

What is Fibrogen stock price valuation
P/E
N/A
P/B
N/A
P/S
0.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.46
The company's EPS rose by 7% YoY and by 4.9% QoQ
FGEN's equity is down by 30% since the previous quarter
The stock's price to sales (P/S) is 93% less than its 5-year quarterly average of 11.4 and 82% less than its last 4 quarters average of 4.6
The company's revenue rose by 5% YoY but it fell by 4.7% QoQ

Efficiency

How efficient is Fibrogen business performance
FGEN's return on assets is down by 33% year-on-year and by 6% since the previous quarter
The company's return on sales rose by 12% YoY
FGEN's return on invested capital is down by 3.7% year-on-year but it is up by 3.1% since the previous quarter

Dividends

What is FGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FGEN.

Financial health

How did Fibrogen financials performed over time
FGEN's total assets is 28% smaller than its total liabilities
FGEN's total assets is down by 31% year-on-year and by 8% since the previous quarter
The quick ratio has contracted by 29% YoY and by 16% from the previous quarter
The company's debt is 200% higher than its equity
FGEN's debt to equity has soared by 85% YoY and by 22% from the previous quarter
The company's debt rose by 47% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.